Loading publications…
The last 5 uploaded publications
β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, Katherine E. Lindblad, Bárbara Maier, Daniela Sia, Marc Puigvehí, Verónica Miguela, María Casanova-Acebes, Maxime Dhainaut, Carlos Villacorta-Martín, Aatur D. Singhi, Akshata Moghe, Johann von Felden, Lauren Tal Grinspan, Shuang Wang, Alice O. Kamphorst, Satdarshan P. Monga, Brian D. Brown, Augusto Villanueva, Josep M. Llovet, Miriam Mérad, Amaia Lujambio (2019). β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma. Cancer Discovery, 9(8), pp. 1124-1141, DOI: 10.1158/2159-8290.cd-19-0074.
Article145 days agoPalbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma
Julien Bollard, Verónica Miguela, Marina Ruiz de Galarreta, Anu Venkatesh, C. Billie Bian, Mark P. Roberto, Victoria Tovar, Daniela Sia, Pedro Molina-Sánchez, Christie B. Nguyen, Shigeki Nakagawa, Josep M. Llovet, Yujin Hoshida, Amaia Lujambio (2016). Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma. Gut, 66(7), pp. 1286-1296, DOI: 10.1136/gutjnl-2016-312268.
Article145 days agoWNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma
Alexander Rialdi, Mary E. Duffy, Alex P. Scopton, Frank Fonseca, Julia N. Zhao, Megan Schwarz, Pedro Molina-Sánchez, Slim Mzoughi, Elisa Arceci, Jordi Abril‐Fornaguera, Austin Meadows, Marina Ruiz de Galarreta, Denis Torre, Kyna Reyes, Yan Ting Lim, Felix Rosemann, Z.M. Khan, Kevin Mohammed, Xuedi Wang, Xufen Yu, Manikandan Lakshmanan, Ravisankar Rajarethinam, Soo Yong Tan, Jian Jin, Augusto Villanueva, Eleftherios Michailidis, Ype P. de Jong, Charles M. Rice, Ivan Marazzi, Dan Hasson, Josep M. Llovet, Radoslaw M. Sobota, Amaia Lujambio, Ernesto Guccione, Arvin C. Dar (2023). WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma. Nature Cancer, 4(8), pp. 1157-1175, DOI: 10.1038/s43018-023-00609-9.
Article145 days agoTranscriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma
Amanda J. Craig, Teresa García‐Lezana, Marina Ruiz de Galarreta, Carlos Villacorta-Martín, Edgar Gonzalez‐Kozlova, Sebastiao N. Martins‐Filho, Johann von Felden, Mehmet Eren Ahsen, Erin Bresnahan, Gabriela Hernandez‐Meza, Ismaïl Labgaa, Delia D’Avola, Myron Schwartz, Josep M. Llovet, Daniela Sia, Swan N. Thung, Bojan Losic, Amaia Lujambio, Augusto Villanueva (2021). Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma. PLoS Genetics, 17(6), pp. e1009589-e1009589, DOI: 10.1371/journal.pgen.1009589.
Article145 days agoOncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC
Marta Piqué‐Gili, Carmen Andreu-Oller, Agavni Mesropian, Roger Esteban-Fabró, Marina Bárcena‐Varela, Marina Ruiz de Galarreta, Carla Montironi, Iris Martinez-Quetglas, Sarah Cappuyns, Judit Peix, Ieva Keraite, Albert Gris‐Oliver, Elisa Fernández-Martínez, Ezequiel Mauro, Miguel Torres‐Martín, Jordi Abril‐Fornaguera, Katherine E. Lindblad, Diether Lambrechts, Jeroen Dekervel, Swan N. Thung, Daniela Sia, Amaia Lujambio, Roser Pinyol, Josep M. Llovet (2024). Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC. JHEP Reports, 6(11), pp. 101212-101212, DOI: 10.1016/j.jhepr.2024.101212.
Article145 days ago